| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8476746 | Molecular and Cellular Endocrinology | 2016 | 11 Pages |
Abstract
In conclusion, bFGF may contribute to orbital inflammation and tissue remodeling in GO, especially through synergistic interaction with PDGF-BB. Multi-target therapy directed at the bFGF and PDGF pathways may potentially be of interest for the treatment of GO.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Sita Virakul, Judith W. Heutz, Virgil A.S.H. Dalm, Robin P. Peeters, Dion Paridaens, Willem A. van den Bosch, Nattiya Hirankarn, P. Martin van Hagen, Willem A. Dik,